Chuanyu Gao, MD, British Urology Researchers in Surgical Training, London, UK, discusses the impact of the COVID-19 pandemic on surgical practices for the treatment of patients with urological cancer. Dr Gao reports that patients who contract COVID-19 within 30 days of undergoing elective surgery have poorer outcomes and are more likely to experience complications than patients who do not contract COVID-19. Dr Gao comments on the need for separate sites for elective surgery to reduce the risk of contracting COVID-19 for surgical patients. Dr Gao also highlights the COVIDSurg-Cancer study, which is investigating the medium-term impacts of COVID-19 on urological cancer outcomes. This interview took place at the virtual European Association of Urology (EAU) Virtual Meeting 2021.